Literature DB >> 8108001

Retinoblastoma: CT and MRI.

R G Beets-Tan1, M J Hendriks, L M Ramos, K E Tan.   

Abstract

To evaluate the effectiveness of CT and MRI at 0.5 T in the diagnosis and staging of retinoblastoma, we studied 11 patients in whom retinoblastoma was clinically suspected. Nine of the eleven had surgically proven retinoblastoma; in the other two a diagnosis of Coats' disease was made. MRI was not as specific as CT for diagnosing retinoblastoma, due to its lack of sensitivity in detecting calcification; it did, however, have superior contrast resolution. On MRI, Coats' disease was reliably diagnosed and easily differentiated from retinoblastoma. Moreover, the greater ability of MRI to differentiate subretinal fluid from tumour also confers high accuracy in measuring tumour size. CT is still the study of choice in the diagnosis of retinoblastoma, but when MRI is available, it should be performed for better differentiation from lesions such as Coats' disease.

Entities:  

Mesh:

Year:  1994        PMID: 8108001     DOI: 10.1007/bf00599199

Source DB:  PubMed          Journal:  Neuroradiology        ISSN: 0028-3940            Impact factor:   2.804


  19 in total

1.  [Comparative evaluation of echography and C.A.T. in diagnosing retinoblastoma].

Authors:  P Nucci; G Modorati; L Pierro; R Alfarano; R Brancato
Journal:  Minerva Pediatr       Date:  1989-03       Impact factor: 1.312

2.  The detection of intracranial calcifications by MR.

Authors:  R F Oot; P F New; J Pile-Spellman; B R Rosen; G M Shoukimas; K R Davis
Journal:  AJNR Am J Neuroradiol       Date:  1986 Sep-Oct       Impact factor: 3.825

3.  Surface-coil MR imaging of orbital neoplasms.

Authors:  J A Sullivan; S E Harms
Journal:  AJNR Am J Neuroradiol       Date:  1986 Jan-Feb       Impact factor: 3.825

4.  Orbit: initial experience with surface coil spin-echo MR imaging at 1.5 T.

Authors:  S W Atlas; L T Bilaniuk; R A Zimmerman; D B Hackney; H I Goldberg; R I Grossman
Journal:  Radiology       Date:  1987-08       Impact factor: 11.105

5.  MR imaging of orbital and ocular disease.

Authors:  D F Sobel; W Kelly; B O Kjos; D Char; M Brant-Zawadzki; D Norman
Journal:  AJNR Am J Neuroradiol       Date:  1985 Mar-Apr       Impact factor: 3.825

6.  0.6 T magnetic resonance imaging of the orbit.

Authors:  J H Edwards; R A Hyman; S J Vacirca; M A Boxer; S Packer; I H Kaufman; H L Stein
Journal:  AJR Am J Roentgenol       Date:  1985-05       Impact factor: 3.959

Review 7.  Magnetic resonance imaging: an emerging technique for the diagnosis of ocular disorders.

Authors:  E V Smith; E S Gragoudas; N H Kolodny; D J D'Amico
Journal:  Int Ophthalmol       Date:  1990-03       Impact factor: 2.031

Review 8.  Retinoblastoma: biology, presentation, and current management.

Authors:  S S Donaldson; L M Smith
Journal:  Oncology (Williston Park)       Date:  1989-04       Impact factor: 2.990

9.  Magnetic resonance imaging versus computed tomography of leukocoric eyes and use of in vitro proton magnetic resonance spectroscopy of retinoblastoma.

Authors:  M F Mafee; M F Goldberg; S B Cohen; E D Gotsis; M Safran; L Chekuri; B Raofi
Journal:  Ophthalmology       Date:  1989-07       Impact factor: 12.079

10.  Intraocular tumors: evaluation with MR imaging.

Authors:  R G Peyster; J J Augsburger; J A Shields; B L Hershey; R Eagle; M E Haskin
Journal:  Radiology       Date:  1988-09       Impact factor: 11.105

View more
  9 in total

1.  Retinoblastoma - MR appearance using a surface coil in comparison with histopathological results.

Authors:  Arne-Jörn Lemke; Iris Kazi; Ulrike Mergner; Paul Ivan Foerster; Heinrich Heimann; Nikolaos Bechrakis; Andreas Schüler; Marie-Isabell Senfft von Pilsach; Michael Foerster; Roland Felix; Norbert Hosten
Journal:  Eur Radiol       Date:  2006-04-25       Impact factor: 5.315

2.  Imaging in the trilateral retinoblastoma syndrome.

Authors:  L J Bagley; R W Hurst; R A Zimmerman; J A Shields; C L Shields; P De Potter
Journal:  Neuroradiology       Date:  1996-02       Impact factor: 2.804

3.  The essence of the Japan Radiological Society/Japanese College of Radiology Imaging Guideline.

Authors:  Yasuyuki Yamashita; Sadayuki Murayama; Masahiro Okada; Yoshiyuki Watanabe; Masako Kataoka; Yasushi Kaji; Keiko Imamura; Yasuo Takehara; Hiromitsu Hayashi; Kazuko Ohno; Kazuo Awai; Toshinori Hirai; Kazuyuki Kojima; Shuji Sakai; Naofumi Matsunaga; Takamichi Murakami; Kengo Yoshimitsu; Toshifumi Gabata; Kenji Matsuzaki; Eriko Tohno; Yasuhiro Kawahara; Takeo Nakayama; Shuichi Monzawa; Satoru Takahashi
Journal:  Jpn J Radiol       Date:  2016-01       Impact factor: 2.374

4.  Comparison of the diagnostic value of MR imaging and ophthalmoscopy for the staging of retinoblastoma.

Authors:  Aman Khurana; Christina A Eisenhut; Wenshuai Wan; Katayoon B Ebrahimi; Chirag Patel; Joan M O'Brien; Kristen Yeom; Heike E Daldrup-Link
Journal:  Eur Radiol       Date:  2012-11-18       Impact factor: 5.315

5.  MR imaging in retinoblastoma.

Authors:  F Barkhof; M Smeets; P van der Valk; K E Tan; F Hoogenraad; J Peeters; J Valk
Journal:  Eur Radiol       Date:  1997       Impact factor: 5.315

6.  Detection of calcifications in retinoblastoma using gradient-echo MR imaging sequences: comparative study between in vivo MR imaging and ex vivo high-resolution CT.

Authors:  F Rodjan; P de Graaf; P van der Valk; T Hadjistilianou; A Cerase; P Toti; M C de Jong; A C Moll; J A Castelijns; P Galluzzi
Journal:  AJNR Am J Neuroradiol       Date:  2014-12-18       Impact factor: 3.825

7.  High resolution magnetic resonance imaging of retinoblastoma.

Authors:  A O Schueler; N Hosten; N E Bechrakis; A J Lemke; P Foerster; R Felix; M H Foerster; N Bornfeld
Journal:  Br J Ophthalmol       Date:  2003-03       Impact factor: 4.638

8.  Guidelines for imaging retinoblastoma: imaging principles and MRI standardization.

Authors:  Pim de Graaf; Sophia Göricke; Firazia Rodjan; Paolo Galluzzi; Philippe Maeder; Jonas A Castelijns; Hervé J Brisse
Journal:  Pediatr Radiol       Date:  2011-08-18

9.  Retinoblastoma in an Adult.

Authors:  Vasudha Garg; Ashumi Gupta; Sonam K Pruthi; Pratima Khare
Journal:  J Cytol       Date:  2018 Apr-Jun       Impact factor: 1.000

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.